...
首页> 外文期刊>Journal of the American College of Surgeons >A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation.
【24h】

A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation.

机译:使用电凝的新型非手术原位结肠直肠癌小鼠模型。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Orthotopic mouse models of human colorectal cancer represent an important in vivo tool for testing chemotherapeutic agents and studying intraluminal factors that may alter the growth of cancers. Currently the orthotopic mouse models of colorectal cancer require either an operative procedure or creation of colitis to implant the cancer cells in rectum. We have developed a nonoperative, minimally invasive technique to create a true orthotopic colon cancer mouse model. STUDY DESIGN: We used human (LS 174T and HT-29) and murine (CRL-2638 and CRL-2639) colon cancer cell lines. Low-dose mucosal coagulation was performed transanally using a specially designed electrode at 1 to 3 predetermined points, 2 to 3 cm from the anus, followed by a transanal instillation of tumor cells (1 x 10(6) cells) in 12 female nude or severe combined immunodeficiency disease mice for each of the 4 groups (n = 48, plus 16 controls). Mouse colonoscope (Coloview) and microCT were used to follow tumor growth. Four mice from each group were euthanized at 1, 2, and 3 weeks. RESULTS: Tumors were detected in 12 of 12 of the CRL-2638, 11 of 12 of the CRL-2639, 7 of 12 of the HT-29 and 12 of 12 mice in the LS 174T groups. Histopathologic evaluation showed that the tumors grew from the colonic mucosa. CRL-2638 and LS 174T exhibited better implantation, faster tumor growth, larger tumor volume, and earlier metastases. MicroCT detected tumors larger than 3 mm, and the colonoscopy detected tumors larger than 1 mm. CONCLUSIONS: Our mouse model is minimally invasive and easy to create and overcomes the limitations of existing models while mimicking the human disease in terms of morphology and biologic behavior. This model opens the doors for colon cancer oncologic studies in an animal model that were previously not possible.
机译:背景:人类大肠癌的原位小鼠模型代表了一种重要的体内工具,可用于测试化学治疗剂和研究可能改变癌症生长的腔内因子。当前,大肠癌的原位小鼠模型需要手术程序或结肠炎的产生以将癌细胞植入直肠。我们已经开发出一种非手术,微创技术来创建真正的原位结肠癌小鼠模型。研究设计:我们使用了人类(LS 174T和HT-29)和鼠(CRL-2638和CRL-2639)结肠癌细胞系。使用特殊设计的电极经肛门在距肛门2至3 cm的1至3个预定点经鼻进行小剂量粘膜凝血,然后经肛门滴注12个雌性裸鼠或裸鼠中的肿瘤细胞(1 x 10(6)个细胞)。 4组中的每组(n = 48,外加16个对照组)的严重联合免疫缺陷病小鼠。使用小鼠结肠镜(Coloview)和microCT追踪肿瘤的生长。在第1、2和3周对每组四只小鼠实施安乐死。结果:在LS 174T组中,在CRL-2638的12只中的12只,CRL-2639的12只中的11只,HT-29的12只中的7只和12只小鼠中的12只中检测到肿瘤。组织病理学评价显示肿瘤从结肠粘膜生长。 CRL-2638和LS 174T表现出更好的植入,更快的肿瘤生长,更大的肿瘤体积和更早的转移。 MicroCT检测到大于3 mm的肿瘤,结肠镜检查检测到大于1 mm的肿瘤。结论:我们的小鼠模型具有微创性,易于创建,并且克服了现有模型的局限性,同时在形态和生物学行为方面模仿了人类疾病。该模型为以前不可能进行的动物模型中的结肠癌肿瘤学研究打开了大门。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号